Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

A novel preclinical model of cocaine and alcohol coabuse

Sep. 6, 2019

Discovery of a selective OX1 receptor antagonist for substance abuse and dependency

Sep. 5, 2019

Could orphan opioid receptor prevent opioid orphans?

Aug. 22, 2019

InterveXion reports interim data from phase II study of IXT-m200 for methamphetamine use disorder

July 30, 2019

Presentation of data for PLX-R18 as prophylactic countermeasure for ARS

July 18, 2019

PledPharma reports results from POP phase I trial of calmangafodipir for paracetamol overdose

July 18, 2019

How mothers drive their offspring to drink

July 15, 2019

Rockefeller University presents kappa-opioid receptor agonists

July 1, 2019

European Commission approves Sixmo to treat opioid dependence

June 27, 2019

Upregulation of STARD1 following endoplasmic reticulum stress mediates acetaminophen hepatoxicity

June 21, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...